32.10
0.34 (1.07%)
0.34 (1.07%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cortexyme Inc | CRTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.34 | 1.07% | 32.10 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 31.70 | 31.2166 | 33.085 | 32.10 | 31.76 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 31.00 | 35.90 | 4.90 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,894 | 122,805 | $ 32.21 | $ 3,955,600 | 297,987 | 22.21 - 73.84 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:56:50 | 3 | $ 31.90 | USD |
Cortexyme Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 946.89M | 29.50M | 15.45M | $ - | $ - | -1.51 | -13.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 3.50k | 2.50% |
Cortexyme News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 32.55 | 33.79 | 30.67 | 32.23 | 174,587 | -0.45 | -1.38% |
| 1 Month | 29.43 | 33.79 | 26.6612 | 30.07 | 171,876 | 2.67 | 9.07% |
| 3 Months | 50.19 | 58.99 | 26.6612 | 36.11 | 241,465 | -18.09 | -36.04% |
| 6 Months | 44.02 | 58.99 | 26.6612 | 40.18 | 154,052 | -11.92 | -27.08% |
| 1 Year | 58.45 | 73.84 | 22.21 | 43.51 | 148,931 | -26.35 | -45.08% |
| 3 Years | 20.00 | 73.84 | 19.35 | 41.90 | 134,394 | 12.10 | 60.5% |
| 5 Years | 20.00 | 73.84 | 19.35 | 41.90 | 134,394 | 12.10 | 60.5% |
Cortexyme Description
| Cortexyme Inc is a clinical-stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases. Its approach is based on the seminal discovery of the presence of Porphyromonas gingivalis or P. gingivalis, and its secreted toxic virulence factor proteases called gingipains. The company operates in only one reportable segment that is developing and commercializing therapeutics. |
